Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FMDV recombinant vaccines and uses thereof

FMDV recombinant vaccines and uses thereof

US Patent 10010605 · Granted Jul 3, 2018

Estimated economic value: $73,356,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant vectors expressing antigens of avian influenza virus and uses thereo2021
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes2021
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020
Reassortant BTV and AHSV vaccines2020
PRRSV minor protein-containing recombinant viral vectors and methods of making a2020
Methods for freeze-drying and rehydrating biologics2020
Inactivated canine influenza vaccines and methods of making and uses thereof2020
Attenuated swine influenza vaccines and methods of making and use thereof2020